Skip to main content

Table 2 Comparisons of surgery-induced changes in serum FGF-19 levels between biliopancreatic diversion (BPD), laparoscopic greater curvature plication (LGCP) and laparoscopic adjustable gastric banding (LAGB) bariatric procedures

From: Impact of gut hormone FGF-19 on type-2 diabetes and mitochondrial recovery in a prospective study of obese diabetic women undergoing bariatric surgery

Bariatric surgery (n) Percent of patients with increase (%) Change from pre- to post-surgery (%)a
Mean (SD) Median (IQR)
BPD (12) 58.3 158.90 (180.60) 121.72 (52.73–152.67)
LGCP (15) 73.3 181.32 (209.65) 135.41 (74.75–172.57)
LAGB (12) 16.7 84.27 (88.49)* 63.28 (41.66–79.24)*
  1. Table shows percentage of patients (%) who exhibited increased serum FGF-19 post-surgery relative to pre-surgery levels. The Wilcoxon signed-rank test was used for within group comparisons of pre- and post-surgery levels (*P < 0.05)
  2. aThe Kruskal–Wallis H test determined there were significant differences in serum FGF-19 between the three surgery types (χ2 = 7.655; P = 0.022)
  3. SD standard deviation, IQR interquartile range